← Leaderboards
Rongsheng Jin
University Of California-Irvine
$17,409,334
Attributed
$23,975,315
Total exposure
19
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,975,315 · 19
By mechanism
R01$20,560,087 · 8
R21$3,389,538 · 8
P41$25,690 · 3
Top collaborators
- Charles Bix Shoemaker8 shared
- Min Dong7 shared
- Lin Mei5 shared
- Xing Dai2 shared
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureToxinComplexProteinsCellsMediatingMolecularAffinityDesignBindingPreventReceptorReceptor BindingNeuronsBaseAntibodiesPublic Health RelevanceSpecificityPathogenesisInsightCrystallizationSerotypingToxic EffectLead
Grant awards (54)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents$1,549,397
R01 · FY2025 · AI
Developing broad-spectrum therapeutics against C. difficile toxins$748,253
R01 · FY2025 · AI · contact PI
Structural studies of the OrfX-type progenitor toxin complex of botulinum neurotoxin$616,816
R01 · FY2025 · AI · contact PI
Developing novel botulism antidotes and a platform for intra-neuronal delivery of nanobodies$194,156
R21 · FY2025 · AI · contact PI
Cell-penetrating botulinum proteases as topical therapeutics$186,516
R21 · FY2025 · AR · contact PI
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents$802,815
R01 · FY2024 · AI
Developing broad-spectrum therapeutics against C. difficile toxins$752,846
R01 · FY2024 · AI · contact PI
Developing novel botulism antidotes and a platform for intra-neuronal delivery of nanobodies$263,914
R21 · FY2024 · AI · contact PI
Cell-penetrating botulinum proteases as topical therapeutics$172,700
R21 · FY2024 · AR · contact PI
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents$865,682
R01 · FY2023 · AI
Developing broad-spectrum therapeutics against C. difficile toxins$772,904
R01 · FY2023 · AI · contact PI
Structure and Function of C. Difficile Toxins$787,630
R01 · FY2022 · AI
Developing broad-spectrum therapeutics against C. difficile toxins$779,693
R01 · FY2022 · AI · contact PI
Structural basis of Rho glucosylation by Clostridium difficile toxins$235,500
R21 · FY2022 · AI · contact PI
Structural basis for recognition of SV2 by type E botulinum neurotoxin$196,250
R21 · FY2022 · AI · contact PI
Developing broad-spectrum therapeutics against C. difficile toxins$798,535
R01 · FY2021 · AI · contact PI
Structure and Function of C. Difficile Toxins$797,212
R01 · FY2021 · AI
Structural basis for recognition of SV2 by type E botulinum neurotoxin$235,500
R21 · FY2021 · AI · contact PI
Structural basis of Rho glucosylation by Clostridium difficile toxins$196,250
R21 · FY2021 · AI · contact PI
Structure and Function of C. Difficile Toxins$804,015
R01 · FY2020 · AI
Molecular mechanisms of botulinum neurotoxin neutralization$567,527
R01 · FY2020 · AI · contact PI
Novel anti-cancer biologics targeting Wnt signaling pathway$180,254
R21 · FY2020 · CA
Structure and Function of C. Difficile Toxins$816,888
R01 · FY2019 · AI
Molecular mechanisms of botulinum neurotoxin neutralization$577,448
R01 · FY2019 · AI · contact PI
Novel anti-cancer biologics targeting Wnt signaling pathway$233,051
R21 · FY2019 · CA
Computational design of inhibitors against botulinum neurotoxin$193,491
R21 · FY2019 · AI · contact PI
Structure and Function of C. Difficile Toxins$848,063
R01 · FY2018 · AI
Molecular mechanisms of botulinum neurotoxin neutralization$587,371
R01 · FY2018 · AI · contact PI
Computational design of inhibitors against botulinum neurotoxin$246,376
R21 · FY2018 · AI · contact PI
Molecular mechanisms of botulinum neurotoxin neutralization$597,917
R01 · FY2017 · AI · contact PI
LRP4 signaling in neuromuscular junction formation$283,689
R01 · FY2017 · NS
Structural mechanism for recognition of host receptor by botulinum neurotoxin A$193,125
R21 · FY2017 · AI · contact PI
Molecular mechanisms of botulinum neurotoxin neutralization$636,248
R01 · FY2016 · AI · contact PI
LRP4 signaling in neuromuscular junction formation$445,915
R01 · FY2016 · NS
Structural and functional studies of botulinum neurotoxin$347,625
R01 · FY2016 · AI · contact PI
Structural mechanism for recognition of host receptor by botulinum neurotoxin A$231,750
R21 · FY2016 · AI · contact PI
Structural and functional studies of botulinum neurotoxin$477,451
R01 · FY2015 · AI · contact PI
LRP4 signaling in neuromuscular junction formation$449,627
R01 · FY2015 · NS
LRP4 signaling in neuromuscular junction formation$464,733
R01 · FY2014 · NS
Structural and functional studies of botulinum neurotoxin$346,969
R01 · FY2014 · AI · contact PI
The amino-terminal domain guides subfamily-specific assembly of ionotropic glutam$298,182
R01 · FY2014 · GM · contact PI
LRP4 signaling in neuromuscular junction formation$477,265
R01 · FY2013 · NS
The amino-terminal domain guides subfamily-specific assembly of ionotropic glutam$286,814
R01 · FY2013 · GM · contact PI
Structural and functional studies of botulinum neurotoxin$230,024
R01 · FY2013 · AI · contact PI
Structural and functional studies of botulinum neurotoxin$147,131
R01 · FY2013 · AI · contact PI
Structural and functional studies of botulinum neurotoxin$487,500
R01 · FY2012 · AI · contact PI
The amino-terminal domain guides subfamily-specific assembly of ionotropic glutam$368,726
R01 · FY2012 · GM · contact PI
The amino-terminal domain guides subfamily-specific assembly of ionotropic glutam$368,726
R01 · FY2011 · GM · contact PI
STRUCTURAL AND FUNCTIONAL STUDIES OF BACTERIAL TOXINS$21,926
P41 · FY2011 · RR · contact PI
STRUCTURAL STUDIES OF BOTULINUM NEUROTOXINS$279
P41 · FY2011 · RR · contact PI
The amino-terminal domain guides subfamily-specific assembly of ionotropic glutam$372,450
R01 · FY2010 · GM · contact PI
Mechanism of Allosteric Modulator Action at the Ionotropic Glutamate Receptor$274,085
R21 · FY2010 · AG · contact PI
STRUCTURAL AND FUNCTIONAL STUDIES OF BACTERIAL TOXINS$3,485
P41 · FY2010 · RR · contact PI
Mechanism of Allosteric Modulator Action at the Ionotropic Glutamate Receptor$156,620
R21 · FY2009 · AG · contact PI